<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04193124</url>
  </required_header>
  <id_info>
    <org_study_id>HEC</org_study_id>
    <nct_id>NCT04193124</nct_id>
  </id_info>
  <brief_title>Prolonged Vasospasm in Subarachnoid Hemorrhage</brief_title>
  <acronym>PVE</acronym>
  <official_title>Clinical Implication of Prolonged Vasospasm in Subarachnoid Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital El Cruce</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital El Cruce</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence and clinical implications of prolonged cerebral vasospasm in patients with
      subarachnoid hemorrhage are unknown.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence and clinical importance of prolonged cerebral vasospasm (after day 21 of
      bleeding) in patients with subarachnoid hemorrhage is unknown.

      Objectives: To determine the prevalence and clinical relevance of prolonged vasospasm in
      patients with subarachnoid hemorrhage secondary to cerebral aneurysm.

      A prospective and observational study was conducted. Adult patients with a diagnosis of
      subarcnoid hemorrhage CT scan or presence of blood in the cerebrospinal fluid were
      incorporated. Patients with vasospasm were followed daily with transcranial doppler. Those
      with technical impossibility to perform transcranial and pregnant Doppler were excluded. Day
      0 was defined, the day of the last bleeding.

      Evaluation: 1) It was considered in patients with prolonged vasospasm: whether or not it was
      associated with clinical manifestation (deterioration of the sensory or new neurological
      deficit) and 2) the magnitude of the vasospasm (mild, moderate or severe) was measured by
      transcranial doppler.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Actual">December 2019</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Clinical implication</measure>
    <time_frame>1 month</time_frame>
    <description>Presence or not of neurological symptoms related to intracranial vasospasm (delayed cerebral ischemia)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gravity of vasospasm by transcranial doppler</measure>
    <time_frame>1 month</time_frame>
    <description>Mild, moderate and severe according to Aaslid scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality assessment</measure>
    <time_frame>six monts</time_frame>
    <description>Mortality was assessed at hospital discharge and at six months</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Neurological recovery</measure>
    <time_frame>six monts</time_frame>
    <description>Neurological recovery at six months according to Glasgow outcome scale</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">109</enrollment>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Vasospasm, Intracranial</condition>
  <arm_group>
    <arm_group_label>Prolonged vasospasm</arm_group_label>
    <description>Adult patients with a diagnosis of subarcnoid hemorrhage CT scan or presence of blood in the cerebrospinal fluid were incorporated. Patients with vasospasm were followed daily with transcranial doppler. Prolonged vasospasm was defined for patients who persisted with vasospasm after day 21 of cerebral bleeding.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>transcranial doppler.</intervention_name>
    <description>Daily monitoring of transcranial doppler until the disappearance of the intracranial vasosparm</description>
    <arm_group_label>Prolonged vasospasm</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with subarachnoid hemorrhage and vasospasm
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Subarachnoid hemorrhage -

        Exclusion Criteria: Pregnancy

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Harders AG, Gilsbach JM. Time course of blood velocity changes related to vasospasm in the circle of Willis measured by transcranial Doppler ultrasound. J Neurosurg. 1987 May;66(5):718-28.</citation>
    <PMID>3553456</PMID>
  </results_reference>
  <results_reference>
    <citation>MASPES PE, MARINI G. Intracranial arterial spasm related to supraclinoid ruptured aneurysms. Acta Neurochir (Wien). 1962 Dec 12;10:630-8.</citation>
    <PMID>13933363</PMID>
  </results_reference>
  <results_reference>
    <citation>Yamaguchi M, Bun T, Kuwahara T, Kitamura S. Very late-onset symptomatic cerebral vasospasm caused by a large residual aneurysmal subarachnoid hematoma--case report. Neurol Med Chir (Tokyo). 1999 Sep;39(9):677-80.</citation>
    <PMID>10563118</PMID>
  </results_reference>
  <results_reference>
    <citation>MÃ¼ller M, Schwerdtfeger K, Zieroth S. Assessment of middle cerebral artery diameter after aneurysmal subarachnoid hemorrhage by transcranial color-coded duplex sonography. Eur J Ultrasound. 2000 Mar;11(1):15-9.</citation>
    <PMID>10717509</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 6, 2019</study_first_submitted>
  <study_first_submitted_qc>December 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>December 6, 2019</last_update_submitted>
  <last_update_submitted_qc>December 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital El Cruce</investigator_affiliation>
    <investigator_full_name>Nestor Pistillo</investigator_full_name>
    <investigator_title>Head of Intensive Care Unit at Hospital El Cruce</investigator_title>
  </responsible_party>
  <keyword>Subarachnoid Hemorrhage</keyword>
  <keyword>Vasospasm, Intracranial</keyword>
  <keyword>Transcranial doppler</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Vasospasm, Intracranial</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

